Mild Cognitive Impairment
1999/03/01 by Ronald C. Petersen, Glenn E. Smith, Stephen C. Waring +3 · 70 citations
Medicine · #Dementia and Cognitive Impairment Research #Cancer-related cognitive impairment studies #Traumatic Brain Injury Research
paper · doi:10.1001/archneur.56.3.303
Abstract
BACKGROUND: Subjects with a mild cognitive impairment (MCI) have a memory impairment beyond that expected for age and education yet are not demented. These subjects are becoming the focus of many prediction studies and early intervention trials. OBJECTIVE: To characterize clinically subjects with MCI cross-sectionally and longitudinally. DESIGN: A prospective, longitudinal inception cohort. SETTING: General community clinic. PARTICIPANTS: A sample of 76 consecutively evaluated subjects with MCI were compared with 234 healthy control subjects and 106 patients with mild Alzheimer disease (AD), all from a community setting as part of the Mayo Clinic Alzheimer's Disease Center/Alzheimer's Disease Patient Registry, Rochester, Minn. MAIN OUTCOME MEASURES: The 3 groups of individuals were compared on demographic factors and measures of cognitive function including the Mini-Mental State Examination, Wechsler Adult Intelligence Scale-Revised, Wechsler Memory Scale-Revised, Dementia Rating Scale, Free and Cued Selective Reminding Test, and Auditory Verbal Learning Test. Clinical classifications of dementia and AD were determined according to the Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition and the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria, respectively. RESULTS: The primary distinction between control subjects and subjects with MCI was in the area of memory, while other cognitive functions were comparable. However, when the subjects with MCI were compared with the patients with very mild AD, memory performance was similar, but patients with AD were more impaired in other cognitive domains as well. Longitudinal performance demonstrated that the subjects with MCI declined at a rate greater than that of the controls but less rapidly than the patients with mild AD. CONCLUSIONS: Patients who meet the criteria for MCI can be differentiated from healthy control subjects and those with very mild AD. They appear to constitute a clinical entity that can be characterized for treatment interventions.
Citations
Cited by
- Hearing Loss and Incident Dementia
- Comparison of the Short Test of Mental Status and the Mini-Mental State Examination in Mild Cognitive Impairment
- Progression of Mild Cognitive Impairment to Dementia in Clinic- vs Community-Based Cohorts
- Depression in Patients With Mild Cognitive Impairment Increases the Risk of Developing Dementia of Alzheimer Type
- Perceived Stress and Cognitive Decline in Chinese‐American Older Adults
- Cognitive decline in the elderly after surgery and anaesthesia: results from the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort
- Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial
- Early-stage dementia and driving: what do older adults want to happen when driving is no longer safe?
- Lipid profiling reveals unsaturated lipid reduction in women with Alzheimer's disease
- Practice guideline update summary: Mild cognitive impairment [RETIRED]
- 7T MRI for neurodegenerative dementias in vivo: a systematic review of the literature
- A task to assess behavioral pattern separation (BPS) in humans: Data from healthy aging and mild cognitive impairment
- Chinese herbal medicine for mild cognitive impairment using mini-mental state examination
- Discovering Hidden Links: Harnessing Similarity Network Fusion to Reveal Common Clusters in Healthy Aging, Mild Cognitive Impairment, and Dementia
- Vascular Contributions to Cognitive Impairment and Dementia
- Serious Games Application for Memory Training Using Egocentric Images
- Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
- ACTA: A Mobile-Health Solution for Integrated Nudge-Neurofeedback Training for Senior Citizens
- Effects of β-hydroxybutyrate on cognition in memory-impaired adults
- Mnemonic Similarity Task: A Tool for Assessing Hippocampal Integrity
- Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies
- Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment
- Machine learning applications in vascular neuroimaging for the diagnosis and prognosis of cognitive impairment and dementia: a systematic review and meta-analysis
- Working memory and control of attention in persons with Alzheimer's disease and mild cognitive impairment.
- Longitudinal deficits to attention, executive, and working memory in subtypes of mild cognitive impairment.
- A re‐examination of Montreal Cognitive Assessment (MoCA) cutoff scores
- Genetic convergence in brain aging and neurodegeneration: from cellular mechanisms to therapeutic targets
- Neurofilament Light Chain as a Potential Biomarker in Plasma for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and a Meta-Analysis
- Mild Cognitive Impairment in Geriatrics
- Exercise interventions for cognitive function in adults older than 50: a systematic review with meta-analysis
- Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease
- Error Monitoring Failure in Metamemory Appraisal: A Visuospatial-Driven Feature of Mild Cognitive Impairment due to Alzheimer’s Disease
- Urban environment exposures and cognitive health: an evidence gap map of systematic reviews
- Catecholaminergic nucleus integrity and Alzheimer's pathology, symptoms, and progression
- Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History
- No associations between blood pressure and brain volumes in a convenience sample of Hispanic/Latino middle-aged and older adults
- The exposome of brain aging across 34 countries
- The COMFORTage project: study protocol for the integration of multiple sources towards personalised preventions at Ace Alzheimer Center Barcelona
- Risk Factors for the Progression of Mild Cognitive Impairment to Dementia
- The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening
- Memory processes in schizophrenia: impact of comorbidity with substance use disorders
- Classification and Epidemiology of MCI
- Representative Functional Connectivity Learning for Multiple Clinical groups in Alzheimer's Disease
- Moving on From HAND: Why We Need New Criteria for Cognitive Impairment in Persons Living With Human Immunodeficiency Virus and a Proposed Way Forward
- MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer’s Disease
- Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. [europepmc]
- Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. [europepmc]
- Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. [europepmc]
- Prevalence of dementia in the United States: the aging, demographics, and memory study. [europepmc]
- Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. [europepmc]
- Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. [europepmc]
- Quantification of five neuropsychological approaches to defining mild cognitive impairment. [europepmc]
- The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. [europepmc]
- Mild cognitive impairment: ten years later. [europepmc]
- APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. [europepmc]
- Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. [europepmc]
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. [europepmc]
- Hearing loss and incident dementia. [europepmc]
- The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. [europepmc]
- Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. [europepmc]
- Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. [europepmc]
- Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. [europepmc]
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. [europepmc]
- The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. [europepmc]
- Mild cognitive impairment: a concept in evolution. [europepmc]
- Plasma phospholipids identify antecedent memory impairment in older adults. [europepmc]
- Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. [europepmc]
- Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. [europepmc]
- Mild Cognitive Impairment. [europepmc]
- Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease. [europepmc]
Related